Target Name: PRF1
NCBI ID: G5551
Review Report on PRF1 Target / Biomarker Content of Review Report on PRF1 Target / Biomarker
PRF1
Other Name(s): PRF1 variant 1 | MGC65093 | Lymphocyte pore-forming protein | HPLH2 | FLH2 | perforin 1 (pore forming protein) | P1 | PERF_HUMAN | Cytolysin | perforin 1 | Lymphocyte pore forming protein | lymphocyte pore-forming protein | Perforin 1 | Perforin 1, transcript variant 1 | PRF1 variant 2 | PFN1 | Perforin 1, transcript variant 2 | cytolysin | Perforin-1 | PFP

PRF1: A Potential Drug Target for Various Diseases

PRF1 (PRF1 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a key regulator of cell growth and differentiation, and is involved in many important cellular processes.

Recent studies have identified PRF1 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because PRF1 is often expressed at high levels in these types of diseases, and may play a role in the development and progression of these conditions.

One of the key reasons why PRF1 is considered a potential drug target is its involvement in cell signaling pathways. PRF1 is a transcription factor that regulates the expression of many different genes, including those that are involved in cell growth, differentiation, and survival. This means that changes in the levels of PRF1 in a cell can have a significant impact on the cell's behavior and functions.

Studies have shown that PRF1 is involved in many important cellular processes, including the regulation of cell proliferation, differentiation, and survival. For example, studies have shown that PRF1 is involved in the regulation of cell growth and that it plays a role in the development of cancer. Additionally, PRF1 has been shown to be involved in the regulation of cell differentiation and cell survival, which may be important for the development of neurodegenerative diseases.

Another reason why PRF1 is considered a potential drug target is its role in the regulation of cellular interactions with the environment. PRF1 is involved in the regulation of many different cellular processes that are important for the cell's ability to interact with its environment. For example, PRF1 is involved in the regulation of cell adhesion, which is important for the formation of tissues and organs.

In addition to its role in cell signaling pathways and cellular interactions with the environment, PRF1 is also considered a potential drug target because of its involvement in the regulation of cellular processes that are important for the development and maintenance of tissues and organs. For example, PRF1 is involved in the regulation of cell proliferation and cell differentiation, which are important for the development and maintenance of tissues and organs.

Overall, PRF1 is a protein that is involved in many important cellular processes that are important for the development and maintenance of tissues and organs. As a result, PRF1 is considered a potential drug target for the treatment of various diseases. Further research is needed to fully understand the role of PRF1 in these conditions and to develop effective treatments.

Protein Name: Perforin 1

Functions: Pore-forming protein that plays a key role in granzyme-mediated programmed cell death, and in defense against virus-infected or neoplastic cells (PubMed:9058810, PubMed:9164947, PubMed:20889983, PubMed:21037563). Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease (PubMed:9058810). Can insert into the membrane of target cells in its calcium-bound form, oligomerize and form large pores. Promotes cytolysis and apoptosis of target cells by facilitating the uptake of cytotoxic granzymes (PubMed:20889983, PubMed:21037563). Promotes cytolysis and apoptosis of target cells by facilitating the uptake of cytotoxic granzymes (PubMed:20038786, PubMed:20225066, PubMed:32299851). Perforin pores allow the release of mature caspase-7 (CASP7) into the extracellular milieu (By similarity)

The "PRF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PRG1 | PRG2 | PRG3 | PRG4 | PRH1 | PRH1-PRR4 | PRH1-TAS2R14 | PRH2 | PRICKLE1 | PRICKLE2 | PRICKLE2-AS1 | PRICKLE2-AS2 | PRICKLE3 | PRICKLE4 | PRIM1 | PRIM2 | PRIM2BP | PRIMA1 | PRIMPOL | PRINS | PRKAA1 | PRKAA2 | PRKAB1 | PRKAB2 | PRKACA | PRKACB | PRKACG | PRKAG1 | PRKAG2 | PRKAG2-AS1 | PRKAG2-AS2 | PRKAG3 | PRKAR1A | PRKAR1B | PRKAR2A | PRKAR2A-AS1 | PRKAR2B | PRKCA | PRKCA-AS1 | PRKCB | PRKCD | PRKCE | PRKCG | PRKCH | PRKCI | PRKCQ | PRKCQ-AS1 | PRKCSH | PRKCZ | PRKCZ-AS1 | PRKD1 | PRKD2 | PRKD3 | PRKDC | PRKG1 | PRKG1-AS1 | PRKG2 | PRKG2-AS1 | PRKN | PRKRA | PRKRIP1 | PRKX | PRKXP1 | PRKY | PRL | PRLH | PRLHR | PRLR | PRM1 | PRM2 | PRM3 | PRMT1 | PRMT2 | PRMT3 | PRMT5 | PRMT5-DT | PRMT6 | PRMT7 | PRMT8 | PRMT9 | PRNCR1 | PRND | PRNP | PRNT | Pro-Neuregulin | PROB1 | PROC | PROCA1 | PROCR | PRODH | PRODHLP | Prohibitin | PROK1 | PROK2 | Prokineticin Receptor (PK-R) | PROKR1 | PROKR2 | Prolactin receptor (isoform 1) | Prolyl 4-hydroxylase | PROM1